Dana Investment Advisors’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-58,740
Closed -$207K 407
2023
Q2
$207K Buy
58,740
+1,088
+2% +$4.88K 0.01% 383
2023
Q1
$243K Buy
+57,652
New +$685K 0.01% 370
2021
Q4
Sell
-20,635
Closed -$233K 330
2021
Q3
$233K Buy
20,635
+5,180
+34% +$63K 0.01% 308
2021
Q2
$152K Buy
+15,455
New +$211K 0.01% 312

Other funds holding ALT

Dana Investment Advisors's ALT Position: Q3 2023 in Review

Dana Investment Advisors sold out of Altimmune (ALT) in Q3 2023, closing a stake of 58,740 shares — an estimated $207K sold.

Dana Investment Advisors first reported a position in ALT in Q2 2021 and held it in 4 quarters. The position peaked at $243K in Q1 2023. 112 funds tracked by Wall St. Rank hold ALT as of Q3 2023.

  • Dana Investment Advisors reported no remaining Altimmune position as of Q3 2023 after selling out during the quarter.
  • Dana Investment Advisors sold 58,740 Altimmune shares in Q3 2023, an estimated $207K.
  • Dana Investment Advisors first reported a position in Altimmune in Q2 2021 and held it in 4 quarters.
  • Dana Investment Advisors's Altimmune position peaked at $243K in Q1 2023.
  • 112 funds tracked by Wall St. Rank held Altimmune as of Q3 2023.

Based on Dana Investment Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.